Stay updated on Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page.

Latest updates to the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page
- Check4 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3; no changes to study data or user-facing functionality.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe UI was updated to Revision: v3.4.2 and the obsolete government-funding notice was removed; no study details were changed.SummaryDifference0.5%

- Check39 days agoChange DetectedAdded a site-wide notice about the lapse in government funding and the NIH Clinical Center status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check46 days agoChange DetectedAdded a glossary toggle and a new revision indicator (v3.4.0). Minor wording updates to the QC date label and the No FEAR Act data notice, including removal of the old v3.3.4 reference.SummaryDifference0.2%

- Check54 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to study details or user-facing features.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded a Locations section with Oklahoma and Utah and updated to Revision: v3.3.3; removed the HHS Vulnerability Disclosure footer.SummaryDifference0.4%

Stay in the know with updates to Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page.